What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 6 minute read Pharma Industry News Lunai Bioworks (NASDAQ: LNAI) tests whether AI-driven patient stratification can de-risk oncology trials Find out how Lunai Bioworks Inc. is using AI to uncover hidden survival signals in oncology trials and what it could mean for future FDA approvals. byVenkateshFebruary 10, 2026